Centessa Pharmaceuticals PLC ADR (CNTA) financials · rev $15.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Centessa Pharmaceuticals PLC ADR (CNTA) rev $15.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $15.0M | N/A |
| Operating Income | -$207.7M | -$201.1M |
| Net Income | -$197.5M | -$235.8M |
| EPS (Diluted) | -$1.46 | -$2.06 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $687.5M | $576.8M |
| Current Assets | $367.9M | $536.4M |
| Cash & Equivalents | $61.3M | $383.2M |
| PP&E | $807.0K | $744.0K |
| Total Liabilities | $160.6M | $175.3M |
| Current Liabilities | $42.9M | $58.0M |
| Long-term Debt | $110.1M | $108.9M |
| Total Debt | $110.1M† | $108.9M† |
| Shareholders' Equity | $526.9M | $401.5M |
| Retained Earnings | -$1.19B | -$988.7M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$193.8M | -$142.1M |
| CapEx | $371.0K | $34.0K |
| Investing Cash Flow | -$418.5M | $31.3M |
| Financing Cash Flow | $291.5M | $364.8M |
| Net Change in Cash | -$321.3M | $255.2M |
| Free Cash Flow | -$194.2M | -$142.1M |
FAQ
What is CNTA P/E and revenue?
Centessa Pharmaceuticals PLC ADR (CNTA) rev $15.0M.
What is CNTA revenue?
Centessa Pharmaceuticals PLC ADR last cached revenue is $15.0M (FY2025).
Is CNTA profitable?
Centessa Pharmaceuticals PLC ADR last cached net income is -$197.5M (FY2025).
What are CNTA total assets?
Centessa Pharmaceuticals PLC ADR last cached total assets are $687.5M (FY2025).
What is CNTA free cash flow?
Centessa Pharmaceuticals PLC ADR last cached free cash flow is -$194.2M (FY2025).
Not investment advice. Cached statements, not a live tape.